Lincoln National Corp Eli Lilly & CO Transaction History

Lincoln National Corp

$3.11 Billion
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$592.2 - $792.28 $1.06 Million - $1.42 Million	1,789 Added 11.7%	17,080 $13.3 Million
Q4 2023 Feb 06, 2024	BUY	$525.19 - $619.13 $259,443 - $305,850	494 Added 3.34%	15,291 $8.91 Million
Q3 2023 Nov 03, 2023	BUY	$434.7 - $599.3 $587,279 - $809,654	1,351 Added 10.05%	14,797 $7.95 Million
Q2 2023 Aug 04, 2023	BUY	$350.74 - $468.98 $176,422 - $235,896	503 Added 3.89%	13,446 $6.31 Million
Q1 2023 May 01, 2023	BUY	$310.63 - $364.82 $64,300 - $75,517	207 Added 1.63%	12,943 $4.44 Million
Q4 2022 Feb 07, 2023	SELL	$321.55 - $374.67 $1.59 Million - $1.85 Million	-4,932 Reduced 27.91%	12,736 $4.66 Million
Q3 2022 Nov 03, 2022	BUY	$296.48 - $337.87 $357,851 - $407,809	1,207 Added 7.33%	17,668 $5.71 Million
Q2 2022 Aug 02, 2022	BUY	$278.73 - $327.27 $1.75 Million - $2.06 Million	6,280 Added 61.68%	16,461 $5.34 Million
Q1 2022 May 09, 2022	BUY	$234.69 - $291.66 $123,212 - $153,121	525 Added 5.44%	10,181 $2.92 Million
Q4 2021 Jan 26, 2022	BUY	$224.85 - $279.04 $102,306 - $126,963	455 Added 4.95%	9,656 $2.67 Million
Q3 2021 Nov 05, 2021	BUY	$221.6 - $272.71 $55,621 - $68,450	251 Added 2.8%	9,201 $2.13 Million
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $103,274 - $133,584	572 Added 6.83%	8,950 $2.05 Million
Q1 2021 May 10, 2021	BUY	$164.32 - $212.72 $76,244 - $98,702	464 Added 5.86%	8,378 $1.57 Million
Q4 2020 Feb 05, 2021	BUY	$130.46 - $172.63 $37,572 - $49,717	288 Added 3.78%	7,914 $1.34 Million
Q3 2020 Nov 09, 2020	BUY	$146.22 - $169.13 $141,687 - $163,886	969 Added 14.56%	7,626 $1.13 Million
Q2 2020 Jul 31, 2020	BUY	$136.42 - $164.18 $144,605 - $174,030	1,060 Added 18.94%	6,657 $1.09 Million
Q1 2020 Apr 24, 2020	BUY	$119.05 - $147.35 $111,549 - $138,066	937 Added 20.11%	5,597 $777,000
Q4 2019 Feb 07, 2020	BUY	$106.92 - $132.43 $12,188 - $15,097	114 Added 2.51%	4,660 $612,000
Q3 2019 Nov 06, 2019	BUY	$106.79 - $116.16 $9,397 - $10,222	88 Added 1.97%	4,546 $508,000
Q2 2019 Aug 06, 2019	BUY	$110.79 - $129.32 $12,962 - $15,130	117 Added 2.7%	4,458 $494,000
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $15,472 - $18,211	139 Added 3.31%	4,341 $563,000
Q4 2018 Feb 08, 2019	BUY	$105.9 - $118.64 $17,791 - $19,931	168 Added 4.16%	4,202 $487,000
Q3 2018 Nov 06, 2018	SELL	$85.86 - $107.31 $12,879 - $16,096	-150 Reduced 3.59%	4,034 $433,000
Q2 2018 Aug 08, 2018	SELL	$75.7 - $86.88 $63,588 - $72,979	-840 Reduced 16.72%	4,184 $357,000
Q1 2018 May 09, 2018	SELL	$74.21 - $87.6 $218,400 - $257,806	-2,943 Reduced 36.94%	5,024 $389,000
Q4 2017 Feb 13, 2018	BUY	$81.94 - $87.89 $341,198 - $365,973	4,164 Added 109.49%	7,967 $673,000
Q3 2017 Oct 31, 2017	SELL	$77.07 - $85.54 $616 - $684	-8 Reduced 0.21%	3,803 $326,000
Q2 2017 Aug 07, 2017	BUY	N/A	3,811	3,811 $313,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

Lilly Endowment Inc Indianapolis, IN

96.9M
Shares

$77.1 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.8M
Shares

$58.7 Billion
1.2% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$52.4 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$40.9 Billion
29.2% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$26.9 Billion
1.24% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lincoln National Corp with notifications on news.

Account